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Abstract
The participation of African Americans in clinical and public health research is essential. However, for a multitude of
reasons, participation is low in many research studies. This article reviews the literature that substantiates barriers to
participation and the legacy of past abuses of human subjects through research. The article then reports the results of
seven focus groups with 60 African Americans in Los Angeles, Chicago, Washington, DC, and Atlanta during the
winter of 1997. In order to improve recruitment and retention in research, the focus group study examined knowledge
of and attitudes toward medical research, knowledge of the Tuskegee Syphilis Study, and reactions to the Home Box
Oce production, Miss Evers’ Boys, a fictionalized version of the Tuskegee Study, that premiered in February, 1997.
The study found that accurate knowledge about research was limited; lack of understanding and trust of informed
consent procedures was problematic; and distrust of researchers posed a substantial barrier to recruitment.
Additionally, the study found that, in general, participants believed that research was important, but they clearly
distinguished between types of research they would be willing to consider participating in and their motivations for
doing so. # 2001 Elsevier Science Ltd. All rights reserved.
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Introduction
The participation of African Americans in clinical and
public health research is essential for addressing
disparities in health status. However, for many different
reasons, participation is low in many research studies.
The authors will first review the literature that sub-
stantiates barriers to participation and focus specifically
on the legacy of the Tuskegee Syphilis Study as a prime
symbol of past abuses of human subjects through
research. The authors will then report the results of
seven focus groups with 60 African Americans in Los
Angeles, Chicago, Washington, DC, and Atlanta.
Conducted in winter, 1997, the focus group study
examined knowledge of and attitudes toward medical
research, knowledge of the Tuskegee Syphilis Study, and
reactions to the Home Box Oce production, Miss
Evers’ Boys, a fictionalized version of the Tuskegee
Study, that premiered in February 1997.
Background
Data on participation rates suggest that African
Americans are especially dicult to recruit into
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research. For example, Arean and colleagues (1993)
used advertisements in local newspapers and radio
stations to recruit elderly adults into a clinical trial.
While this was successful for whites, only 1% of those
who responded belonged to an ethnic or racial minority
group. Ballard, Nash, Raiford and Harrell (1993)
reported that, as of 1989, only 9.9% or 60 of 607
participants in a study of Alzheimer’s disease were
African American. Svensson (1989) examined 50 clinical
trials for new medications reported in Clinical Pharma-
cology and Therapeutics over a 3-year period. He found
that the enrollment of minorities in the trials was
substantially less than their proportion in the population
where the trials were located. Eastman (1996) reported
that African Americans comprised only 5% of partici-
pants in cancer clinical trials. Reynolds (1996) cited a
similar statistic for the National Cancer Institute’s
Prostate, Lung, Colorectal, and Ovarian Cancer Screen-
ing Trial with only 6% of its participants being African
American.
In the era of AIDS, El-Sadr and Capps (1992) state
‘‘the under-representation of minorities among partici-
pants in HIV-related drug trials is of serious concern,
and of ethical, social, and scientific importance’’. Many
authors have documented numerous barriers to partici-
pation in research. Those barriers fall into the following
categories: 1) broader health care system issues; 2)
characteristics of potential participants; 3) public knowl-
edge, perceptions, and attitudes toward researchers and
research; 4) behaviors and attitudes of providers and
researchers. Furthermore, numerous authors have de-
termined that lack of knowledge of research, mistrust,
fear of exploitation, and the Tuskegee Syphilis Study are
significant barriers. Therefore, our study, and conse-
quently, the literature review, focuses primarily on those
issues and factors associated with them.
Knowledge about research and its purposes is an
important factor in willingness of African Americans to
participate in clinical trials. In a study with 8 African
Americans, Roberson (1994) found that African Amer-
icans, Hispanics, and Native Americans were generally
familiar with the term ‘‘experimental study’’, but were
less familiar with the term ‘‘clinical trial’’. African
Americans, Hispanics, and Native Americans defined
the purpose of an experimental study as ‘‘a study to help
people’’, ‘‘an experiment where people are used as
guinea pigs’’, and a ‘‘study to learn about a disease and
medication’’ (Roberson, 1994, p. 2689). Respondents
believed that the benefits of participation were to ‘‘help
others’’, ‘‘help find a cure’’, ‘‘educate families’’, and to
‘‘assist with medical coverage’’ (Roberson, 1994, p.
2689). El-Sadr and Capps (1992) suggest that the lack of
knowledge about the nature, purpose and procedures of
medical research is a significant barrier to recruitment
that requires patience, building of trust, and a thorough
educational program about the purpose of clinical trials.
Knowledge of research procedures and purposes is
often linked to access to health care. Many African
Americans receive primary health care in emergency
rooms and receive care from several physicians, ‘‘none
of whom may be knowledgeable about the available
protocols nor interested enough in the patient to refer
him/her for inclusion in a clinical trial’’ (Shavers-
Hornaday, Lynch, Burmeister and Torner, 1997, p.
35). Additionally, patients may seek care at neighbor-
hood institutions, where little research is conducted (El-
Sadr & Capps, 1992). While much research takes place
at university medical centers, many African Americans
may feel that the university medical facility ‘‘is available
only to select segments of the population (e.g., white,
middle class) and not to the minority populations’’, thus
limiting their participation in studies (Welsh, Ballard,
Nash, Raiford & Harrell, 1994, p. 40).
Several authors describe researchers and physician
biases as barriers to recruitment of African Americans.
Despite ethical standards that would prohibit such
actions, researchers may limit minority participation in
clinical trials because of their beliefs that ‘‘there is
greater diculty in obtaining African American com-
pliance with a study protocol and that they have higher
attrition rates’’ (Shavers-Hornaday et al., 1997, p. 37).
Swanson & Ward (1995) describe researchers’ biases
about barriers to participation as reflections of the
researchers’ own prejudices against the populations of
interest for the research. They include ‘‘failure to
accommodate cultural and economic diversity of poten-
tial study participants, failure to recognize that restric-
tive studies do not fully assess safety and ecacy of new
treatments or preventive interventions for all popula-
tions, claims that statistical power will be reduced if
women and minorities are included, inaccurate beliefs
that certain populations are not at risk for specific
conditions or illnesses, and failure to establish research
clinics in minority institutions’’ (Swanson and Ward,
1995, p. 1753). They state that researchers use a
common excuse for exclusion of minorities when they
describe them as ‘‘hard to reach’’ (p. 1753), characteriz-
ing the population as dicult as opposed to under-
standing the broader context in which the community
lives. Researchers may be reluctant to spend limited
funds on actively recruiting minorities. Another factor
that may limit recruitment is the small number of
minority researchers (Swanson and Ward, 1995), and
limited relationships between investigators and minority
health care providers and caregivers.
Central to the conduct of research in community
settings is the issue of trust between the investigator, the
agency and community members. In a study of 1,900
subjects in biomedical research, Kass, Sugarman,
Faden, and Schoch-Spana (1996) found that trust in
the respondents’ physician was the critical factor
determining enrollment in a study. Paradoxically, trust
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contributed to the participants’ lack of attentiveness to
the consent process, with many reporting their decision
to participate occurring prior to reading the consent
form. While Kass and colleagues (1996) did not analyze
their results to examine racial differences, trust in the
physician may not be present for many African
Americans. For example, during testimony in 1990
before the National Commission on AIDS, Mark Smith,
MD., then from Johns Hopkins University, described
the African American community as ‘‘already alienated
from the health care system and the government’’
(Thomas & Quinn, 1991, p. 1499). Freedman (1998),
in her study of 13 African American women, describes
her interviewees’ lack of trust in their white providers,
their belief that white doctors overlook diseases pre-
valent in the African American community, and their
concern that they may be used as guinea pigs.
Distrust of researchers by many African Americans
poses a well documented, serious challenge to investi-
gator efforts to meet the mandates that require inclusion
of minorities in research set out by the National
Institutes of Health (NIH), the federal agency in the
US that funds a significant amount of biomedical and
public health research and sets the national research
agenda. Gamble (1997) asserts that the history of
medical experimentation on African Americans during
slavery laid the foundation of distrust. Harris, Gorelick,
Samuels and Bempong (1996) confirm a ‘‘legacy of
mistrust’’, stating:
Southern blacks became a prime source for medical
school dissection experiments and autopsy speci-
mens. Fearful of this practice, some expressed the
hope to die in the summer months when dissection
classes were not in session. This practice continued in
the postbellum South in the form of ‘night-doctors’
who stole and dissected the bodies of blacks (p. 631).
Abuse of human subjects involved in research has
been well documented, and modern examples include
the Human Radiation Experiments conducted by the
US Government, birth control studies on women of
color, the Brooklyn Jewish Chronic Disease Hospital
and the Willowbrook Hospital cases, among others (see
the Final Report of the President’s Advisory Committee
for a discussion of abuses of human subjects). However,
the legacy of the Tuskegee Syphilis Study has emerged as
the most frequently cited contemporary event to justify
African Americans’ suspicion of research (Quinn, 1997;
Swanson & Ward, 1995; El-Sadr & Capps, 1992;
Thomas & Quinn, 1991; Gamble, 1993; Hatch, Moss,
Saran, Presley-Cantrell & Mallory, 1993). The Tuskegee
Syphilis Study of Untreated Syphilis in the Negro Male,
1932–1972, was the longest non-therapeutic study in
medical history. Conducted by the US Public Health
Service with 399 African American men as subjects
and 201 African American men as controls in
Macon County, Alabama, the study followed the
natural history of the disease. The participants in the
study were never informed that they had the disease,
and when penicillin became the standard of care, the
men were prevented from receiving treatment. It is
estimated that between 28 and 100 men died as a result
of syphilis.
Smith believes that the Tuskegee Syphilis Study
‘‘provides validation for common suspicions about the
ethical even-handedness in the medical research estab-
lishment and in the federal government, in particular,
when it comes to Black people’’ (Thomas & Quinn,
1991, p. 1499). Before the National Commission on
AIDS, Dr. Smith stated, ‘‘[The Black] communities’
perspective on medical research has a historical basis
which sometimes outweighs the demonstrable integrity
and commitment of individual investigators’’ (Thomas
& Quinn, 1991, p. 1503).
Today, many believe the Study’s legacy hampers
recruitment for research among African Americans.
During testimony to the National Commission on
AIDS, Alpha Thomas, health educator with the Dallas
Urban League, stated: ‘‘So many African American
people that I work with do not trust hospitals or any of
the other community health care service providers
because of that Tuskegee Experiment. It is like if they
did it then, they will do it again’’ (Thomas & Quinn,
1991, p. 1503). In an effort to recruit African American
women for a research project on hormone replacement
therapy, Lynda Powell, professor of Preventive Medi-
cine at Rush-Presbyterian-St. Luke’s Medical Center in
Chicago, initially denied the Tuskegee Study had an
impact on recruitment, describing it as old, obscure, and
a study that only physicians remembered. Even prior to
the premiere of Miss Evers’ Boys in 1997, Powell
recognized her error, stating, ‘‘Each woman [African
American recruiter] related a story about Tuskegee
passed on by parents and grandparents. . .These were
educated, talented women who were deeply affected. I
thought only researchers knew about it’’ (Condor, 1997,
p. 1).
In a telephone survey of 218 African American and
203 white residents of Jefferson County, Alabama,
Green, Maisiak, Wang, Britt, and Ebeling (1997) found
empirical evidence of the impact of the study. Fifty-two
percent of African Americans were aware of the
Tuskegee Study compared to 46% of whites. Twenty-
two percent of African Americans compared to 10% of
whites reported that, because of the Study, they were less
willing to participate in research. Green and colleagues
(1997) also found that African Americans were more
likely to believe that people are sometimes treated
poorly in research and that African Americans, in
particular, are likely to be mistreated.
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James Jones, the author of Bad Blood: The Tuskegee
Syphilis Experiment } A Tragedy of Race and Medicine,
the definitive published history of the study, states, ‘‘No
scientific experiment inflicted more damage on the
collective psyche of black Americans than the Tuskegee
Study’’ (Jones, 1992, p. 38). In part, as a response to this
harmful legacy, in 1996, at a meeting at Tuskegee
University, a group of individuals formed the Tuskegee
Syphilis Study Legacy Committee. In its report to the
Centers for Disease Control and Prevention (CDC) in
May 1996, the committee argues, ‘‘the study has become
a powerful symbol for the fear of exploitation in
research. . .’’ (Gamble & Fletcher, 1996, p. 7). Gamble
states, ‘‘The strengthening of safeguards and the reforms
in research standards that followed the public disclosure
of the abuses of the Tuskegee Syphilis Study have been
insucient to change African Americans’ historically
based fears of medical research’’ (1993, p. 37).
To address the numerous barriers, a number of
researchers suggest strategies for increasing participa-
tion in research among African Americans. One area in
which many researchers suggest specific strategies is the
relationship between researchers and the African Amer-
ican community. Such strategies include: raising aware-
ness through outreach programs, local churches and
community organizations; publicity campaigns targeted
to African Americans; increasing awareness about
studies among doctors; using community-centered com-
munication involving trusted individuals, and involve-
ment and commitment of culturally-sensitive staff
(Freedman, 1998; Swanson and Ward, 1995; Welsh et
al., 1994; Shavers-Hornaday et al., 1997; Harris et al.,
1996; El-Sadr & Capps, 1992). Other strategies include
use of incentives like financial compensation, therapeu-
tic interventions, provision of health care, access to
needed services, and provision of transportation services
to facilitate participation (El-Sadr & Capps, 1992; Welsh
et al., 1994; Shavers-Hornaday et al., 1997; Swanson and
Ward, 1995). Patients who have no previous conception
of a clinical trial need ‘‘an extensive educational effort’’
about trials, sampling, responsibilities of researcher and
participant, and other issues in order to understand and
participate in clinical trials (El-Sadr & Capps, 1992).
Swanson and Ward (1995) suggest multiple strategies in
the categories of community methods, health care
provider and facilities strategies, individual and family
strategies, and modifications in research protocols,
procedures and trial management in order to improve
recruitment of minority participants into research.
While there are numerous strategies for increasing
participation, some researchers call for a better under-
standing of the underlying distrust and cultural context
in which African Americans consider research. Shavers-
Hornaday et al., (1997) consider distrust a major barrier
to the recruitment of African Americans to clinical
trials, and call for further research on attitudes, beliefs
and barriers to participation among African Americans.
Roberson (1994) states that research is needed as ‘‘little
is know about the role of mistrust as a variable that
might influence participation’’ (p. 2690). Similarly,
Swanson and Ward (1995) call for further research to
study minority communities to determine those factors
that both enhance clinical trial accrual and present
challenges to clinical trial recruitment (p. 756). Jones
(1993) specifically challenges us to deal with the impact
of the Tuskegee Syphilis Study when he says, ‘‘To the
extent the Tuskegee Study continues to sow suspicions
and distrust, it remains a problem that must be
addressed’’ (p. X).
While the Tuskegee Study is not the only barrier to
African Americans’ participation in research, since it
ocially ended in October 1972, its legacy continues
through legend, fiction, mass media, music, and
documentary studies. For example, in 1992, ABC
Prime-time Live and NOVA both produced programs
about the study. In 1996, a popular television series, NY
Undercover, focused on the study, linking it to the issue
of AIDS as a form of genocide. In 1997, Home Box
Oce (HBO) premiered a movie, Miss Evers’ Boys, a
fictionalized account of the study based on David
Feldshuh’s Pulitzer nominated play. The central char-
acter in Miss Evers’ Boys is based on Eunice Rivers, the
African American nurse who worked on the study for
more than 30 years. Eighteen percent of African
American households with HBO watched the premiere
of the movie on February 22, with an overall 8% of all
19.2 million HBO subscribing households viewing it
(Personal communication, Conner, February 27, 1997).
Additionally, the movie is available through video stores
nationwide for home viewing.
There were two rationales that contributed to this
current study. While researchers have documented
numerous barriers to the recruitment of African Amer-
icans into research programs, few articles actually utilize
data from African American participants to examine
these issues. Therefore, this study sought to directly
listen to the voices of African Americans through focus
groups, particularly as the premiere of Miss Evers’ Boys
brought the Tuskegee Syphilis Study into the public eye
again. Specifically, the study sought to understand
attitudes toward research among African Americans,
to assess knowledge of and beliefs about the Tuskegee
Syphilis Study, to identify strategies to overcome
barriers to participation, and to examine the impact of
viewing Miss Evers’ Boys on focus group participants’
attitudes.
Methods
Since most of the published literature on barriers to
participation are either literature reviews, data from very
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small samples or observations from researchers/provi-
ders, focus groups were chosen as the methodology for
this study because they offered an opportunity to
explore participants’ responses to many of the issues
identified in the literature, examine their reactions more
fully, and to allow new areas of inquiry to emerge. The
research design called for eight focus groups, two in each
of four major regions of the United States: Mid-Atlantic
(Washington DC), South (Atlanta), Midwest (Chicago),
and West Coast (Los Angeles) that HBO had selected as
premiere sites for Miss Evers’ Boys. Local chapters of
the civic groups, 100 Black Men and 100 Black Women,
assisted in recruitment of participants. Additionally, in
Chicago, health outreach workers from the College Park
Authority, a local community based organization,
recruited participants. These particular groups were
selected to help with recruitment because while they all
serve African Americans, the populations they reach
differ by class and education, thereby providing a
broader pool of potential participants. Key contact
people in each organization received instructions on
screening criteria and recruitment procedures. Once
potential participants were identified, research assistants
contacted each individual to complete a more detailed
screening.
While the research aim was to recruit groups that were
balanced in terms of gender and age, with socio-
economic status (SES) as the primary segmentation
variable, the goal was not to recruit a representative
sample. For the purpose of this study, researchers
defined SES by annual household income and highest
level of education attained. Researchers identified an
income of $20,000 or less as low income with low
educational level defined as high school diploma/GED
(general education development test) or less. Moderate
income was defined as $30,000 or above with any college
or above being designated as higher educational level.
A professional African American moderator con-
ducted all sessions. A notetaker was present at all
sessions which were also audiotaped. The format for
each group included a discussion, the viewing of Miss
Evers’ Boys, and further discussion. All notes and tapes
were transcribed verbatim. All participants provided
informed consent.
Data analysis
All transcripts and notes were utilized in the analysis.
Initial reading of notes and transcripts focused on
identifying key themes, words and phrases that occurred
in response to each question. Then, the authors
examined themes across the transcripts and developed
broader conceptual domains. Quotes were extracted that
illustrated common responses and themes across groups.
Characteristics of participants
A total of 60 individuals participated in four moderate
income and three low-income focus groups. Due to
logistical diculties, the group of moderate-income
participants in Chicago failed to take place. Of these
60, 20 men and 40 women participated with a median
age of 37. Participants ranged in age from 19 to 78. Five
participants had less than a high school education and
another 5 had a high school diploma or its equivalent.
Ten participants reported some college with 6 having
attended vocational or technical school. Sixteen had a
college degree, and 10 participants had a graduate
degree. Twenty-four participants reported annual in-
comes of less than $20,000 per year, with the majority of
them reporting less than $10,000 annual income. Six
participants reported annual income between $20,000
and $30,000, with 10 reporting incomes between $30,000
and $50,000. Twelve participants reported incomes
above $50,000. Thirty-nine had previously known of
the Tuskegee Study. Nine participants reported some
prior participation in research. For 8 participants, there
is only data on gender available (see Table 1).
Table 1
Site, income of group members, and number of participants
City Income of group members Number of participants
Washington, DC moderate 5
Washington, DC moderate 9
Los Angeles low 7
Los Angeles moderate 10
Atlanta low 10
Atlanta moderate 7
Chicago low 12
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Results
In general, geographic region, gender and SES had no
perceivable influence on participant knowledge of or
feelings toward either medical research in general or the
Tuskegee Syphilis Study in particular. While some
participants from the moderate-income groups were
somewhat more knowledgeable about research, there
were no differences between groups on most issues.
Participants were virtually unanimous from the outset
that African Americans needed to be very cautious
about when and how they interacted with the medical
system or government agencies. This caution was
applied to all aspects of involvement with the medical
community, including treatment and initiatives
designed to promote the health and well being of
African Americans through appropriate preventive
care and behaviors. In relation to medical research,
there was consensus that African Americans should
generally avoid involvement given knowledge of past
abuses and the inability to be certain that abuses would
not reoccur.
Understanding of research
The moderator posed the following question, ‘‘What
comes to mind when I say medical research?’’ The
common responses ranged from descriptions of types of
research, research as a profit making endeavor, to
unethical research studies. Numerous participants de-
scribed different purposes of research such as, ‘‘It’s also
endeavoring to find cures for various diseases, too’’, as
well as different types of research stating ‘‘Yeah, they
use some type of procedure or medication, maybe, or
cutting you open, taking out something or adding
something. Something that hasn’t been proven yet’’, and
‘‘Things like clinical trials. I mean like testing, using
certain people as test cases’’.
Another common response linked research to
financial gain with comments such as: ‘‘It’s an
industry onto itself’’; ‘‘Making money’’; and ‘‘An awful
lot of that I think is driven by profit, unfortunately’’.
A number of participants immediately responded in a
negative manner. As one man said, ‘‘Uh-oh. A lot of
stuff has come to light recently due to declassification
of information. Every thing is done in the name
of medical research. Humans can be guinea pigs as
well. It makes me think ‘uh-oh’’’. This quote
illustrates a theme of suspicion mentioned in several
groups, ‘‘If people knew half the things they were
exposed to, knowingly or unknowingly, they would be
surprised’’.
Knowledge of research terms and procedures
To gauge knowledge about research, the moderator
asked several questions about common research terms
such as confidentiality, informed consent, placebo,
clinical trial, protocol and randomization. In general,
level of knowledge was not very high. While many
participants understood confidentiality, others had
misconceptions about the term. While one participant
described it as ‘‘No one sees you going in or out’’,
another thought it meant, ‘‘The data will only be used in
a positive manner’’.
While a significant number of participants understood
what a placebo is, others did not know the term at all.
Those that responded to the question, ‘‘What is a
clinical trial?’’ were correct in that it often involved
placebos for the purpose of testing the ecacy of
treatments or medications. While a few correctly defined
randomization, many clearly did not understand the
term, with 2 participants describing it as ‘‘not given any
thought’’ or ‘‘no specific target group’’. Few understood
the term protocol. One participant described protocol
as, ‘‘If they did something and they’re trying to cover it
up’’.
In general, participants understood the term, in-
formed consent, to mean that they would receive
information about the research process in order for
them to fully consent. However, many participants
expressed strong concerns about the nature and value of
the informed consent process. Many stated a belief that
providing consent was the equivalent of ‘‘signing away
your rights’’ and that the process was designed primarily
to protect hospitals and doctors from any legal
responsibility. As one participant stated, ‘‘If you give
consent, then you don’t have any legal rights’’. Another
participant feared the evolving motivations of the
researchers:
Now, once you sign that, you know there’s a certain
amount of license, and I think that we’ve seen in the
past where people have these ideas that their project
or their grant, or their aspirations to get a Nobel
Prize, or to publish an article in the Journal of the
American Medical Association and. . .you know,
after a while they lose sight of who you are. . ..
Participants also indicated the challenge of truly
giving informed consent due to diculty in fully
understanding the complexities of research. One parti-
cipant described the diculty understanding the consent
forms, ‘‘You sit there and you read it but you don’t
necessarily understand what you’re reading when you
sign the paper’’. One person recommended a solution to
the lack of understanding of consent forms by suggest-
ing, ‘‘And it has to be in layman’s terms. Some of the
ones. . . were in hieroglyphics’’. Another participant
V.S. Freimuth et al. / Social Science and Medicine 52 (2001) 797–808802
added, ‘‘and most people don’t even read it before they
sign it’’. One participant raised the concern that the
consent form may not fully represent the risks of the
research, ‘‘People don’t want to bias their results, so
they won’t tell you all of it’’.
Past participation in medical research
Very few participants had ever participated in
medical research. Of the 9 who had, most indicated
involvement in surveys or providing samples of body
fluids. Only one indicated more intensive involvement in
a study that included hormone injections, computed
axial tomography (CAT) scans and positron emission
tomography (PET) scans. For some participants, there
was confusion between research and treatment, espe-
cially if the treatment was provided at a teaching
hospital. One man stated, ‘‘There’s a lot of hospitals
that the interns, a lot of times you go in there and they’re
doing a lot of experimenting’’. Another participant
described that physician changes in treatment regimes as
research, ‘‘They be experimenting on me a lot of times.
They give me some pills sometimes, then they give you
some other medication’’. Another woman echoed this
concern:
Because I’ve taken some medicine that almost killed
me, it was a cancer cure and I didn’t think I had a
choice and I found out after I talked to the doctor,
after three treatments that almost killed me, I asked
him: I don’t think a mule could live through those
treatments and the doctor told me some of them
don’t. That was his answer. So they were experi-
menting on me. . .
When one participant asked, ‘‘Is a flu shot preventa-
tive or is it research?’’ a woman responded, ‘‘Both.
Yes, I caught the flu one week after I had one of
them one year, then one year I didn’t get it at all’’.
Clearly, the distinction between treatment, preven-
tion and research was blurry for many participants.
While several participants commented that, ‘‘We all
have [participated] unknowingly’’, and ‘‘Sometimes
you’re in medical research when you don’t know
it’’, others had specific ideas about the type of
research conducted without consent. When one partici-
pant suggested, ‘‘Like take a commercial for a new
painkiller and we watch it and then we go out and buy
it and if nothing goes wrong it works’’, another went on
to say:
I think there is a covert way of doing medical
research and then there is more honest research done
out in the open. As far as the process, I don’t know.
Like when I first started going to school, my mother
didn’t allow us to get those immunizations. She was a
nurse and she said it was research and it wasn’t
proven.
Motivations of researchers
Participants correctly reported that universities, hos-
pitals, corporations and government agencies carry out
research. They reported a variety of motivations of the
researchers that ranged from positive ones such as, ‘‘I
think they are trying to learn or trying to cure some of
these diseases’’, to more skepticism that they are
motivated by money as reflected in this man’s comment,
‘‘. . .but the bottom line is everything is money because if
they make it work on you, then by production, they’ll
get wealthy’’.
Who benefits from research
The majority of participants saw the benefits of
research for the public. A few recognized that research
might not immediately benefit its actual participants.
One man stated, ‘‘I would like to say in the early stages,
I don’t think the patient benefits but now, if they keep
medical research going on and they refine it . . ., later on,
that person might receive the benefits’’. One participant
raises the complexity of the benefits and potential costs
of research for African Americans:
. . .medical research in this country is second to none.
It’s excellent. We are all beneficiaries. It’s very good
and very important. We have to take a lot of this }
like everything that we have to do as black people, we
have to go into it with these mental gymnastics. So
it’s not cut and dried. It’s not black and white and so
we have to be very wary of how we approach this
system.
Several participants questioned the likelihood that
African Americans will benefit from much of the
research conducted in the US. This was a common
sentiment: ‘‘My challenge is, being African Americans,
will we have access to the findings, whatever they
discover, to make us well?’’
Motivations for participation in research
Despite the overwhelming predisposition against
participation, participants in this study provided new
insights when they identified several motivations for
participation in research. These include personal moti-
vations to help themselves or a loved one through
treatment provided as part of the research (typically in
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relation to a chronic or terminal illness), altruism, and
financial compensation. For a number of participants,
their own experience with a life-threatening or severe
chronic illness might facilitate their willingness to
participate. One participant who suffered from ulcera-
tive colitis said she would be willing if she gained,
‘‘Better relief and finding out more, then coming out
with another drug that could help eliminate symptoms’’.
Another participant mentioned a theme from several
groups, ‘‘I would participate if I was dying of a disease
and it was fatal and I was in the last stages’’. While
another person echoed that same motivation, she
illustrated some misunderstanding of the process of
randomization in research when she stated:
I was going to say if I was a victim of maybe a long-
term illness and there were no other options or
alternatives for me but I would like to know that I
am on the more humane aspect of it. And what I
mean by that is that I have a choice and I’m not
selected for the one that doesn’t receive any type of
treatment.
A number of participants saw monetary reimburse-
ment as a significant incentive. Another participant
expressed the importance of research for all. One woman
said she would be willing to participate ‘‘To find
whatever diseases that are occurring, to find out the
solution to that, or cure’’. One man illustrated the value
of research in blunt terms, ‘‘Because if nobody do it,
somebody gonna die, I mean, more people gonna die’’.
Willingness to participate in research
Participants in the focus groups identified several
factors that would affect their actual willingness to
participate in research. One person indicated a concern
about privacy and the use of data, ‘‘Privacy. I want to
try to maintain as much of my privacy as possible. You
know, how much confidentiality will I really receive?
What will be done with my information?’’ Another
person expressed a common issue when he stated,
‘‘What would make me participate is being made aware
before I commit to it of what I’m actually gonna be
asked to do’’. Finally, one person raised the importance
of trust in his primary provider as a critical factor in his
willingness to participate in research: ‘‘I would think
that my primary provider would have to endorse the
research. He would have to put an endorsement on what
they were doing because at this stage, I trust my doctor’’.
There was a wide range of opinions on willingness to
participate in research with some participants indicating
absolute unwillingness and others considering some
types of research. However, one critical finding from
the focus groups was participants’ distinctions between
types of research in which they would be willing to
participate. Participants were most willing to consider
participation in non-invasive research such as complet-
ing a survey, participating in a group discussion or
allowing assessments of their health behaviors. One
participant reported, ‘‘I do all kinds of surveys, I’m a
survey person’’, and another responded that he would be
willing to have researchers ‘‘asking questions about my
past medical history’’. However, research focusing on
individual behaviors was criticized for its implication
that behaviors of African Americans were the primary
cause of health problems.
Other participants reported willingness to participate
if they perceived the risk to be low. For example, one
person echoed a sentiment expressed by several when she
said, ‘‘If they want something I excrete, that’s fine’’.
Many expressed concerns over adverse consequences to
their own health; one man’s comment sums it up, ‘‘No
side effects, no side effects, no life threatening, it’s not
life threatening or side effects’’. Unwillingness increased
significantly in relation to invasive procedures such as
injections or ingestion of experimental medications.
Many participants perceived such procedures as extre-
mely high risk due to the inability of participants to
know for sure what they were receiving and what
negative effects it could have on them. One participant
summed up a common reaction, ‘‘I might do it if it’s
research where they’re taking something like fluid
samples from me. But if it’s injecting anything, no’’.
Another participant stated a frequent concern, ‘‘. . . they
could be lying about what they’re doing with the
needle’’.
Certainly, the Tuskegee Syphilis Study provided
adequate justification for many who expressed unwill-
ingness to participate in research. One man observed, ‘‘I
have a friend that went through some medical research
. . . but me, myself, I’ve always been skeptical about it
because of this Tuskegee incident’’. That distrust was
evident in numerous responses across the groups; one
participant spoke passionately, ‘‘I feel like all diseases
were created by research anyway, so why should I
participate and help them make more?’’
Knowledge and perceptions of the Tuskegee Syphilis
Study
The majority of participants were familiar with the
Tuskegee Study, though most lacked specific and correct
information about the exact nature, extent and length of
the study. All knew that it involved a study of African
American men who had syphilis and did not receive
treatment. One woman gave an emotional account:
They promised them things that they had no
intention of delivering while they got sick and [when]
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they told the people conducting it that they were
getting sick and they [researchers] were like, we’ll
take care of it but they had no intention because this
is what they wanted to see, how it affected the human
body so they let it go and it was horrible.
A significant number of participants mistakenly
believed the men in the study had been purposely
injected with syphilis, echoed here in one man’s
comment, ‘‘I heard people were given syphilis, that they
were injected with it, to see what would happen’’. Others
held different misconceptions about the study ranging
from confusion that prisoners were involved to one
man’s comment, ‘‘. . . they killed the whole town, the
whole town died behind that thing’’.
While most participants who knew about the study
reported learning it from a PBS special, magazine
articles, and an episode of ‘‘New York Undercover’’,
one reported reading Jones’ book, Bad Blood, and
another learned about it through an AIDS class.
There was fairly widespread belief that the Tuskegee
Syphilis Study was typical of other research projects,
particularly when African Americans were involved.
Comments included: ‘‘It was typical of the way that
blacks, especially men, were exploited’’, and ‘‘Well, this
is clearly racism. . . it was perceived that black people
were of less value and. . . this kind of experiment was
okay to do on black people. If these were white men. . . it
never would have happened’’. From one woman’s
childhood, she reported, ‘‘My mother was from North
Carolina. When she was a teenager, they had student
doctors to kidnap certain people and she was almost
kidnapped in one of these incidents’’.
Several participants expressed anger that they had
never been taught more about the Tuskegee Study, and
saw the lack of detailed information as a significant
factor in the misinformation and rumors about govern-
ment conspiracies and genocide. One participant linked
the lack of information on the study with the creation of
myths and rumors:
It is interesting that this happened relatively recently
but we don’t have the complete information. And it’s
not our fault. We go on what we heard and if we
don’t have the complete facts, you can imagine what
we’ll think. That is how the rumor mill gets started. If
we are educated on it, and this film could educate us.
It is a footnote in history. But if we don’t have the
full information, we will fill in the blanks.
Many participants identified ongoing ‘‘experiments’’
and ‘‘conspiracies’’ that they likened to the study,
including Agent Orange (an herbicide used in the
Vietnam War that has been associated with health
outcomes), the measles vaccine study in Los Angeles in
the 1990’s, and immunizations. Myths persist despite the
facts about such studies. For example, in the measles
study referred to by several participants, the vaccine was
an investigational drug approved by the US Food and
Drug Administration, and there were no fatalities from
its administration. However, this quote reflects a
common concern:
One of the most famous studies that has just been
done in the last 2 or 3 years is the measles study
where the measles vaccine was not approved by the
government that they were using on black babies and
babies in Haiti and the islands and here in the United
States, even here at } where those kids died.
Many participants view HIV/AIDS as an example of
an experiment deliberately introduced to harm people of
African descent. One woman reported, ‘‘Guinea pigs. I
have a strong belief that syphilis and AIDS originated
from a laboratory experiment. That’s what they used
people for’’. Others echoed these sentiments in different
cities:
I think it is still going on now. Like AIDS, it was
man-made but it kind of got out of hand. Like the
flu, chicken pox and polio. It’s still going on. And
then the HIV in Africa and Haiti, Uganda and these
countries where it’s very high. Also, again, on 60
Minutes, they had where the doctors said that the
batch of polio vaccine was tainted but it was too late
to stop it and so these countries don’t sue, you know,
they just die and nobody cares in the medical field.
Several participants did indicate a belief that the
Tuskegee Study represented the way things ‘‘used to be’’
and that some improvements had been made. However,
virtually none of the participants could specifically
identify steps that have been taken to improve the
protection of human subjects.
Reactions to Miss Evers’ boys
Following their viewing of the movie, participants
expressed mixed reactions. Many participants were
concerned about the emphasis on African American
involvement in the study to the exclusion of the white
doctors from the US Public Health Service. A number of
participants were angered by Miss Evers’ actions and
could not understand how she continued to participate.
Others countered that the racism and sexism prevalent
at that time should be considered, and some questioned
the way the movie focused attention on her role rather
than the role of the government. Several individuals
found the movie to provide simply one more indication
that, ‘‘You can’t trust the [profanity] white man’’. A
small number also criticized the way the movie
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emphasized traditional black stereotypes of ‘‘naivete´’’
and ‘‘ignorance’’. Many were upset with the extremely
small and meaningless compensation provided to the
participants.
A significant number of viewers still questioned
whether the men were deliberately injected with syphilis
as illustrated by this participant’s comment, ‘‘Is it
possible they injected those men with syphilis? I mean
it was a government study so the government was
policing themselves so who’s to say they didn’t inject
those men with syphilis?’’ For many viewers, it
confirmed their distrust of the government as in this
man’s comment, ‘‘My reaction to the movie, it just
confirmed my belief about the conspiracy in the United
States against black people’’. A number of other viewers
were skeptical of research and treatment initiatives. One
man stated, ‘‘And this thing right here, about the
deception that’s going on. Today I sit here and wonder,
did they really plant the viruses or the diseases that’s
going on now?’’, while a woman came back to an issue
raised in many groups, ‘‘Oh, it just goes to show you
that if you get like a pneumonia shot, you just don’t
know what you’re getting’’. The deception of the men in
the study was particularly troublesome for many
participants. As one woman stated, ‘‘What disturbed
me was the lie, the lie that was told from the beginning
about the study’’.
In addition to the concern that the movie downplayed
the role of the government, participants questioned why
whites were not included in the study since they
presumably had syphilis too, they wanted to know more
about the families of the men involved and how they
were affected, and were appalled that no one was held
accountable. Overall, despite a variety of concerns about
the factual accuracy of the movie, there was a general
consensus that it provided enough information to
understand what had happened at Tuskegee.
Few participants were aware of any specific ethical
safeguards that were implemented following the dis-
closure of the Tuskegee Study. Nonetheless, there was
concern about how effective such requirements would be
since it would amount to the government attempting to
police itself. Few perceived that available legal options
would be effective, particularly if one had provided
informed consent.
Watching the movie stimulated many to link the
unethical treatment of the men in the study with a
number of incidents of actual or perceived mistreatment
by the federal government. One woman reported, ‘‘Like
the most recent here in L.A. with the crack cocaine being
brought in by the government. This is the latest one of
the investigations, so it’s like, we just don’t trust, it’s not
trusting the government any more’’. Another raised
concerns about Agent Orange, ‘‘I have relatives who are
going through this stuff with Agent Orange. What made
me feel so bad was that the government let them go so
long before they started trying to do something about
it’’. One participant linked the Tuskegee Study with
today’s mental health system by stating, ‘‘You know it is
continuing today with mental health clinics in black
neighborhoods. They are giving them drugs to keep
them crazy so they can continue to have business. Same
things as in the Tuskegee Study’’.
Finally, several participants drew larger conclusions
about the relationship between African Americans, the
government, and American society in general. One
woman raised genocide as her concern, ‘‘. . .that’s the
overall government but I still feel that we have to charge
genocide, you know, we, as a people, are still being
destroyed. . . because everything that’s being done in
America is to eliminate the people of color’’.
Finally, one participant saw the movie as an explana-
tion about the dramatic differences in perceptions about
the trial of O.J. Simpson for murder, ‘‘The movie really
explains the O.J. Simpson phenomena. It underscores
the reasoning behind many black people’s distrust of
institutions. Hearing things like this adds fuel to the fire.
It is a fundamental distrust of institutions which makes
it easier to believe things like the CIA brought crack into
our neighborhood’’.
Race, trust and research
Distrust of white researchers was a common theme.
Some saw racism as the motivation behind mistreatment
in research as illustrated in this woman’s comment, ‘‘But
the white man always has the idea that we’re so inferior
that we’re like animals so why not kill them; why didn’t
they pick the white man and do it to him, give him the
syphilis thing’’. One man articulated the linkage between
race and trust when he said:
I think that most of the people who are in control of
research don’t look like me, and I don’t have
confidence in how they perceive my value and my
worth. I would be very reluctant to give anybody a
blank check with respect to experimenting with my
body and my life, my health.
While many participants documented the events and
reasons for distrust, some suggested this must be
remedied. One participant stated, ‘‘So all this mistrust
got to be corrected at some point if the black community
is going to participate actively in any kind of ongoing
research’’. Another participant suggested that, for her to
trust researchers, she would ‘‘need to make sure that
white people are also in the study’’. Finally, one asked
for understanding of the depth of the mistrust, ‘‘. . .when
you talk about blacks and some of our concerns you will
see they’re not paranoid, that there is some
foundation. . .’’.
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One man offered an example of how researchers could
increase trust, ‘‘I feel that if there needs to be some
research done, they [researchers] should be willing to
offer themselves in medical research. As a participant’’.
However, a woman’s statement illustrated some of the
challenges facing researchers when potential participants
may not fully understand research, ‘‘If I can have a say
so or a choice in or some options, yeah. Understand all
there is and then choose the option that I want’’.
Discussion
It is important to recognize that despite differences
between focus groups on levels of education and income,
many common perceptions and issues arose. While
certainly results of focus groups are not generalizable to
the population, the results suggest that researchers must
take a number of active approaches to increase knowl-
edge, improve communication and strengthen trust in
order to enhance recruitment and retention of African
Americans in research. Our findings suggest a limited
understanding of research, and the presence of mis-
conceptions that might have an impact on participation.
However, this study also finds that participants, in
general, recognize the value of research, and make
distinctions between the types of research they would
find acceptable for their own participation.
Enhancing potential participants’ understanding of
informed consent and research procedures is a clear
mandate from the participants in this study. Providing
complete information in terms that are clearly under-
stood by potential participants is critical. Conducting
formative research with potential subjects and commu-
nity members prior to beginning recruitment efforts will
assist in determining levels of literacy and innovative
ways in which information on studies can be presented.
Pretesting all consent materials and utilizing readability
programs will facilitate the development of consent
materials whose language is appropriate for the audi-
ence.
One crucial first step is to develop a comprehensive
communication campaign about research. To facilitate
motivation and participation in different types of
research, the public must clearly understand what
research is, its terms and procedures, and most
importantly, the purposes of research. Specifically,
communication about research and its purposes must
deal with many respondents’ misconception of potential
personal benefits from participation in research. Com-
munication to promote participation in research must
appeal to the self-interest of those in the target
population while, at the same time, truthfully acknowl-
edging that research is not always without risk for those
who participate. While some participants in clinical
trials may benefit, it must be clear to them that the
production of scientific knowledge is the primary
purpose of clinical research.
Increasing trust between African Americans and
researchers is a serious concern. To facilitate this, it is
critically important for researchers to provide factual
accounts of the Tuskegee Study and other research
controversies to the public and potential participants in
order to avoid development of myths that will further
hamper recruitment. Researchers must be proactive in
addressing scientific misconduct. Certainly, the media
plays a powerful role in highlighting such misconduct,
and it behooves researchers to work closely with media
to provide accurate accounts of research protocols and
current protections for human subjects. While Miss
Evers’ Boys’ is a fictionalized account, it remains one
example of a media portrayal of research that influences
public perceptions of research. It is clearly not in the
best interests of researchers to gloss over such accounts
or to downplay their resonance with African Americans.
Honest disclosure and dialogue provide a strong
foundation for development of trust.
Furthermore, while many professionals downplay the
link between instances of true scientific misconduct and
conspiracy theories, participants made a direct link
between lack of information about real research abuses
and the development of rumors and conspiracy theory.
Therefore, it is necessary to acknowledge that many
African Americans view research within the context of
contemporary racism, urban legends and mistrust in
health care and the larger society, and that their
concerns and fears have a legitimate basis in historical
reality. While this broader societal issue of mistrust is
critical, it is beyond the scope of researchers to address
alone. However, working towards developing more
trusting relationships within the context of research
can potentially advance that issue within public health
and health care in general. This is a critical step in
beginning to address disparities in health status experi-
enced by African Americans.
Incentives are one strategy used to enhance recruit-
ment into research. While some of the literature
advocated the use of incentives (El-Sadr & Capps,
1992; Welsh et al., 1994; Shavers-Hornaday et al., 1997),
and certainly many respondents stated that incentives
such as financial compensation and access to care would
impact their willingness to participate, we must urge
some caution on this strategy for enhancing recruitment
and retention. There is the danger particularly for very
low-income individuals without access to good care, that
such incentives could prove to be unintentionally
coercive.
While many discuss the importance of African
American investigators and research staff as a means
to recruit more African Americans, this alone is not
sucient to increase trust. The class and education gap
of investigators can still exist, and certainly the
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participation of African American researchers and
health professionals in the Tuskegee Study did not
insure that misconduct would not occur. One area in
which to seek change in the capacity of researchers to
work effectively with communities is in the Schools of
Medicine and Public Health where future researchers are
being trained. Professional preparation programs must
actively address issues of culture, race and class, create
opportunities for students to work with populations that
differ from the student by race, ethnicity or class, and
aggressively teach ethics to enhance professional skills
that can reduce distrust.
The voices of participants in this study speak strongly
of suspicion and distrust. As Dr. David Satcher, former
Director of CDC and current Assistant Secretary of
Health and Human Services and Surgeon General of the
US, stated, ‘‘The distrust is hurting us. I think we’ve got
to really focus on it’’ (Trafford, 1997, p. a19). The results
of this study offer suggestions to overcome this distrust
and to increase knowledge of research that ultimately
may enhance participation by African Americans in
necessary clinical and public health research, improve
access to care, and impact the disparities that influence
the quality of life for many African Americans.
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